Clinical trial protocol for continuous glucose monitoring in critical care at Hospital Clinic of Barcelona ( CGM ‐ UCI23 )
Nursing in Critical Care · 2025
DOI: 10.1111/nicc.13198 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Nursing in Critical Care, 2025. Verfasst von Marc Pañero-Moreno und 2 weiteren Autor:innen. Beteiligte Einrichtung: Critical Care Nurse, Hospital Clinic of Barcelona, Barcelona, Catalonia, Spain. Hauptthemen laut MEDLINE: Blood Glucose, COVID-19, Critical Care, Hyperglycemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dexcom, Official College of Nurses of Barcelona (COIB), Catalan Society of Intensive and Critical Medicine (SOCMIC).
Abstract (Originalsprache)
Background
Hyperglycaemia is common in intensive care units (ICUs), with a prevalence of up to 86.2%, increasing mortality. Technology has evolved towards continuous glucose monitoring (CGM), and its use in ICUs began especially during the coronavirus pandemic (COVID‐19). Various studies have evaluated the reliability of CGM, indicating that it is safe for use in critically ill patients.
Aim
The aim of this study was to compare the use of CGM with point‐of‐care glucose (POC‐G) testing in ICU. Specific objectives include evaluating the glycaemic control, the frequency of POC‐G measurements, the incidence of hyperglycaemia, hypoglycaemia and morbidity and mortality at 90 days. Study Design An experimental, controlled and randomized clinical trial with a single‐blind design will be conducted at Hospital Clinic of Barcelona (HCB). A sample size of 376 participants will be recruited and randomly assigned to two groups: an experimental group, where glycaemic management will be based on CGM; and a control group, where glucose will be managed through POC‐G testing, with a blinded CGM.
Results
The primary variable considered will be time in range (TIR), with secondary outcomes including, time above range (TAR), time below range (TBR), number of POC‐G measurements, incidence of hyperglycaemia and hypoglycaemia, and mortality. Hypothesis testing will use the Kolmogorov–Smirnov test to assess data normality, with appropriate statistical tests applied, considering a p ‐value
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Critical Care Nurse, Hospital Clinic of Barcelona, Barcelona, Catalonia, Spain.
- Barcelona Clinical Research Foundation - August Pi i Sunyer Biomedical Research Institute (FRCB-IDIBAPS), Barcelona, Catalonia, Spain.
- PhD Programme in Medicine and Translational Research, University of Barcelona, Barcelona, Catalonia, Spain.
- Department of Fundamental and Clinical Nursing, University of Barcelona, Barcelona, Catalonia, Spain.
- General Nursing Supervisior, Hospital Clinic of Barcelona, Barcelona, Catalonia, Spain.
ORCID-Profile: Marc Pañero-Moreno, Eva Maria Guix-Comellas, Alberto Villamor-Ordozgoiti
Förderung
- Dexcom
- Official College of Nurses of Barcelona (COIB)
- Catalan Society of Intensive and Critical Medicine (SOCMIC)
Zitieren
APA
Pañero-Moreno, M., Guix-Comellas, E. M., & Villamor-Ordozgoiti, A. (2025). Clinical trial protocol for continuous glucose monitoring in critical care at Hospital Clinic of Barcelona ( CGM ‐ UCI23 ). Nursing in Critical Care. https://doi.org/10.1111/nicc.13198
Vancouver
Pañero-Moreno M, Guix-Comellas EM, Villamor-Ordozgoiti A. Clinical trial protocol for continuous glucose monitoring in critical care at Hospital Clinic of Barcelona ( CGM ‐ UCI23 ). Nursing in Critical Care. 2025. doi:10.1111/nicc.13198
BibTeX
@article{PaeroMoreno2025,
author = {Pañero-Moreno, Marc and Guix-Comellas, Eva Maria and Villamor-Ordozgoiti, Alberto},
title = {Clinical trial protocol for continuous glucose monitoring in critical care at Hospital Clinic of Barcelona ( CGM ‐ UCI23 )},
journal = {Nursing in Critical Care},
year = {2025},
doi = {10.1111/nicc.13198}
}
EUVIMED